Search

everythinglearnresearchcommunity

for

Search:↓

Insulin resistance is significantly linked to a higher risk of depression in women with PCOS.

People with polycystic ovary syndrome may have a higher risk of heart problems due to abnormal nervous system control of their heart and blood pressure.

Vitiligo is not linked to coeliac disease, but a small number of alopecia areata patients may have it, suggesting they should be tested for coeliac disease.

Testosterone and dihydrotestosterone affect hair growth, and new techniques like the folliculogram help study it, but fully understanding hair growth is still complex.

Melatonin improved mental health and metabolism in women with PCOS.

Women with PCOS are more likely to have fatty liver disease, especially if they have metabolic problems.

Accurate diagnosis is key for treating different kinds of hair loss, and immune response variations may affect the condition and treatment results.

FAGA diagnosis uses blood tests and trichoscopy, with treatments like topical minoxidil, oral anti-androgens, and hormone-modulating drugs.

Microneedle arrays with nanotechnology show promise for painless drug delivery through the skin but need more research on safety and effectiveness.

Flutamide effectively treats female pattern hair loss with low doses showing good liver tolerance.

The conclusion is that we need more effective hair loss treatments than the current ones, and these could include new drugs, gene and stem cell therapy, hormones, and scalp cooling, but they all need thorough safety testing.

The conclusion is that hirsutism should be diagnosed and treated because it affects quality of life and may signal other health problems.

Systemic glucocorticosteroids are a primary treatment for various skin conditions but require careful management due to potential side effects and relapses.

Certain genetic variations in the SHBG gene are linked to an increased or decreased risk of PCOS in Mediterranean women.

Many skin patients have mental health issues, but few dermatologists are well-versed in treating these conditions.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

Hair loss requires customized treatments based on its various causes and types.

Treat genetic hair loss early with FDA-approved medications and consider hair transplantation.

Alopecia is linked to various health and mental conditions, impacts life quality, and needs medical attention beyond its cosmetic effects.

Testosterone may help increase sexual events for women with low libido due to antidepressants.

Losing eyelashes or eyebrows can be a sign of many different health problems and needs a careful approach to treat effectively.

DHT's role in hair loss is important, but measuring its level for diagnosis is questionable.

Minoxidil effectively treats female pattern hair loss.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Women with PCOS have a higher risk of diabetes, heart problems, certain cancers, and mental health issues, but early treatment can help manage these risks.

Some treatments work for common baldness, but there's less evidence for other hair loss types, and more research is needed.

Chlormadinone acetate is a strong, well-tolerated hormone used in birth control and hormone therapy with benefits for menstrual pain and skin conditions.

Finasteride shows promise for female hair loss, but more research needed.

Premature ovarian insufficiency (POI) can harm women's sexual health, and they may benefit from hormone therapy and counseling.

Combining laser hair removal with topical eflornithine is recommended for better results in treating unwanted facial hair.